Filings Intelligence
Company filings profile · CIK 0001636282

Spyre Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Spyre Therapeutics, Inc. (SYRE): 26 filings in the last 90 days vs 41 in the prior 90 (filing-velocity cooling ↓ · 0.63×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 8, 2026. Source-linked, daily-refreshed.

Material 8-K events — Spyre Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 7, 2026Entry into a Material Agreement; Financial Statements and Exhibits↗
Sep 8, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Aug 25, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Aug 4, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Jun 15, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗

Watch Spyre Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Watch this company →See a sample alert

Insider transactions (Form 4 / 3 / 5)

FiledForm
Oct 2, 20264↗
Oct 2, 20264↗
Oct 2, 20264↗
Sep 3, 20264↗
Sep 3, 20264↗
Sep 3, 20264↗
Aug 10, 20264↗
Aug 5, 20264↗
Aug 5, 20264↗
Jul 2, 20264↗
Jul 2, 20264↗
Jul 2, 20264↗
Jun 26, 20264↗
Jun 23, 20264↗
Jun 23, 20264↗
Jun 3, 20264↗
Jun 3, 20264↗
Jun 3, 20264↗
May 29, 20264↗
May 29, 20264↗

Recent filings

FiledFormDetail
Oct 7, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits ↗
Oct 6, 2026424B5 424B5 ↗
Oct 5, 2026424B5 424B5 ↗
Oct 2, 20264 FORM 4 ↗
Oct 2, 20264 FORM 4 ↗
Oct 2, 20264 FORM 4 ↗
Oct 1, 2026144 ↗
Oct 1, 2026144 ↗
Oct 1, 2026SCHEDULE 13G ↗
Sep 30, 2026144 ↗
Sep 8, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Sep 3, 20264 FORM 4 ↗
Sep 3, 20264 FORM 4 ↗
Sep 3, 20264 FORM 4 ↗
Sep 1, 2026144 ↗
Aug 25, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Aug 14, 2026SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A ↗
Aug 10, 20264 FORM 4 ↗
Aug 7, 2026144 ↗
Aug 7, 2026144 ↗
Aug 5, 20264 FORM 4 ↗
Aug 5, 20264 FORM 4 ↗
Aug 4, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Aug 4, 202610-Q 10-Q ↗
Aug 3, 2026144 ↗
Jul 2, 20264 FORM 4 ↗
Jul 2, 20264 FORM 4 ↗
Jul 2, 20264 FORM 4 ↗
Jul 1, 2026144 ↗
Jun 26, 20264 FORM 4 ↗
Jun 26, 2026S-3ASR S-3ASR ↗
Jun 25, 2026144 ↗
Jun 23, 2026144 ↗
Jun 23, 20264 OWNERSHIP DOCUMENT ↗
Jun 23, 2026SCHEDULE 13D/A ↗
Jun 23, 20264 FORM 4 ↗
Jun 22, 2026144 ↗
Jun 15, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Jun 3, 20264 FORM 4 ↗